-
In early 2025, Evonik announced the expansion of its AQUAVI® Met-Met production facility in Singapore. This move aims to meet the growing demand for high-quality methionine in aquaculture, enhancing feed efficiency and sustainability in the region.
- In September 2024, DSM-Firmenich announced the EU authorization of HiPhorius™, a next-generation phytase enzyme. This enzyme enhances phosphorus digestibility in animals, reducing the need for costly inorganic phosphorus supplements and improving growth rates and feed conversion ratios. HiPhorius™ is approved for use in poultry, swine, and aquaculture across the European Union. The enzyme's advanced formulation ensures superior product forms, delivering enzyme activity effectively during all feed production processes. This development underscores DSM-Firmenich's dedication to providing sustainable and efficient solutions for the animal nutrition industry.
- In March 2025, Adisseo completed the acquisition of Nor-Feed, a French company specializing in plant-based specialty ingredients for animal nutrition. This acquisition strengthens Adisseo's portfolio in natural feed additives, aligning with the industry's shift towards sustainable and plant-based solutions.
- In April 2025, DSM-Firmenich announced a share repurchase program to cover share-based compensation plans and reduce capital. The program commenced with an initial €580 million, with plans to increase to €1 billion upon the completion of the previously announced sale of the company's stake in the Feed Enzymes Alliance. The repurchase program aims to return value to shareholders and optimize the company's capital structure. This initiative demonstrates DSM-Firmenich's commitment to enhancing shareholder value and maintaining financial flexibility.
- In February 2025, Kemin launched Pathorol, a supplement designed to improve hepatopancreas health in shrimp. Initially available in India, Thailand, Vietnam, Indonesia, and Singapore, this product addresses the growing demand for sustainable aquaculture practices.
